CWC22 Antikörper (C-Term)
Kurzübersicht für CWC22 Antikörper (C-Term) (ABIN927947)
Target
Alle CWC22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- KIAA1604 antibody was raised in rabbit using the C terminal of KIAA1604 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
KIAA1604 Blocking Peptide, (ABIN5614339), is also available for use as a blocking control in assays to test for specificity of this KIAA1604 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CWC22 (CWC22 Spliceosome-Associated Protein Homolog (CWC22))
-
Hintergrund
- KIAA1604 may be involved in pre-mRNA splicing. Synonyms: Polyclonal KIAA1604 antibody, Anti-KIAA1604 antibody, CWC22 spliceosome-associated protein homolog, S. cerevisiae antibody, EIF4GL antibody, KIAA1604 antibody, NCM antibody, fSAPb antibody.
Target
-